Detalhe da pesquisa
1.
Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia.
Hematol Transfus Cell Ther
; 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008596
2.
Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia.
Leuk Res
; 140: 107482, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552548